projects:workgroups:transfusion
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
|
projects:workgroups:transfusion [2019/12/13 02:45] cgreich |
projects:workgroups:transfusion [2019/12/13 04:05] (current) cgreich |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ==== OHDSI Transfusion Working Group ==== | ==== OHDSI Transfusion Working Group ==== | ||
| + | |||
| + | <WRAP box justify round> | ||
| === MISSION === | === MISSION === | ||
| Line 6: | Line 8: | ||
| Transfusions are special treatments which are currently in active research by the FDA BEST and the [[https://www.nhlbi.nih.gov/science/recipient-epidemiology-and-donor-evaluation-study-reds-program|REDS-IV]] program. The current OMOP CDM allows only partial capture of relevant transfusion information to support the various research use cases (see below). This Working Group intends to close that gap. | Transfusions are special treatments which are currently in active research by the FDA BEST and the [[https://www.nhlbi.nih.gov/science/recipient-epidemiology-and-donor-evaluation-study-reds-program|REDS-IV]] program. The current OMOP CDM allows only partial capture of relevant transfusion information to support the various research use cases (see below). This Working Group intends to close that gap. | ||
| + | |||
| + | </WRAP> | ||
| == Use Cases == | == Use Cases == | ||
projects/workgroups/transfusion.1576205108.txt.gz ยท Last modified: 2019/12/13 02:45 by cgreich
Page Tools
